Biologicals in the treatment of psoriasis: The Indian perspective
Psoriasis is a common inflammatory skin disorder characterized by itchy erythematous papules and plaques topped with silvery white scales. It has a chronic relapsing course and is associated with significant morbidity and reduction in the quality of life. Therapy of psoriasis is challenging. Topical...
Main Authors: | Ajit B Janagond, Aparna Palit |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2017-01-01
|
Series: | BLDE University Journal of Health Sciences |
Subjects: | |
Online Access: | http://www.bldeujournalhs.in/article.asp?issn=2468-838X;year=2017;volume=2;issue=1;spage=9;epage=13;aulast=Janagond |
Similar Items
-
Treatment challenges in the management of moderate-to-severe plaque psoriasis – role of secukinumab
by: Malakouti M, et al.
Published: (2016-10-01) -
Secukinumab in psoriasis patients with prior ustekinumab treatment: Results of a single-center experience
by: Ting-Shun Wang, et al.
Published: (2017-03-01) -
Apremilast coadministered with secukinumab for safe and effective control of psoriasis with resultant reduction of maintenance dose of the biologic
by: Abhishek De, et al.
Published: (2019-01-01) -
Treatment response in patients with moderate-to-severe psoriasis who had inadequate response to prior secukinumab
by: Tai-Siang Chiu, et al.
Published: (2019-01-01) -
Initial Results of Secukinumab Drug Survival in Patients with Psoriasis: A Multicentre Daily Practice Cohort Study
by: Juul M.P.A. van den Reek, et al.
Published: (2018-04-01)